{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:09:29Z","timestamp":1785881369338,"version":"3.56.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.jhep.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T23:23:42Z","timestamp":1361229822000},"page":"1096-1103","source":"Crossref","is-referenced-by-count":15,"title":["Safety and efficacy of peginterferon-\u03b12a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C"],"prefix":"10.1016","volume":"58","author":[{"given":"Faisal M.","family":"Sanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dujana","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Al-Mdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Al-Shoail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad","family":"Al-Ashgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Al Meshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Qahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayssa","family":"Saadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid I.","family":"Bzeizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Aleid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.02.004_b0005","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00007890-199510000-00007","article-title":"The impact of pretransplantation hepatitis C infection on the outcome of transplantation","volume":"60","author":"Pereira","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.02.004_b0010","doi-asserted-by":"crossref","first-page":"c72","DOI":"10.1159\/000089090","article-title":"Effects of chronic viral hepatitis on graft survival in Saudi renal transplant patients","volume":"102","author":"Mitwalli","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jhep.2013.02.004_b0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00007890-199803150-00011","article-title":"Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients","volume":"65","author":"Legendre","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.02.004_b0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00007890-199808270-00010","article-title":"Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20years","volume":"66","author":"Hanafusa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.02.004_b0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007890-200208270-00001","article-title":"Management of chronic viral hepatitis before and after renal transplantation","volume":"74","author":"Gane","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2013.02.004_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"55","author":"European Association for the Study of the Liver","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.02.004_b0035","first-page":"739","article-title":"Increased expression of human monocyte HLA-DR antigens and Fc-gamma receptors in response to human interferon in vivo","volume":"53","author":"Rhodes","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2013.02.004_b0040","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1365-2036.2006.03151.x","article-title":"Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2013.02.004_b0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-6143.2003.30113.x","article-title":"Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy","volume":"3","author":"Baid","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.02.004_b0050","first-page":"958","article-title":"Renal allograft function in patients with chronic viral hepatitis B and C treated with interferon alpha","volume":"27","author":"Durlik","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jhep.2013.02.004_b0055","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cld.2006.08.025","article-title":"Hepatitis C in transplant recipients of solid organs, other than liver","volume":"10","author":"Wells","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2013.02.004_b0060","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1432-2277.2008.00831.x","article-title":"Pegylated interferon-alpha-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study","volume":"22","author":"Pageaux","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2013.02.004_b0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3748\/wjg.v18.i1.55","article-title":"Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients","volume":"18","author":"Aljumah","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2013.02.004_b0070","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.02.004_b0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.02.004_b0080","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.02.004_b0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1478-3231.2011.02714.x","article-title":"Hepatitis C virus treatment pre- and post-liver transplantation","volume":"32","author":"Roche","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2013.02.004_b0090","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-6143.2006.01255.x","article-title":"Pegylated interferon alpha-2b for patients with HCV recurrence and graft fibrosis following liver transplantation","volume":"6","author":"Heydtmann","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.02.004_b0095","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2010.03280.x","article-title":"Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients","volume":"10","author":"Morales","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2013.02.004_b0100","unstructured":"Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN\/SRTR 2010 Annual Data Report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, <http:\/\/www.srtr.org\/annual_reports\/2010\/509d_ki.htm>; 2011 [accessed 18th August 2012]."},{"key":"10.1016\/j.jhep.2013.02.004_b0105","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jhep.2008.05.002","article-title":"Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin","volume":"49","author":"Berenguer","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.02.004_b0110","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2893.2008.01019.x","article-title":"Pegylated interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies","volume":"15","author":"Xirouchakis","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2013.02.004_b0115","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/lt.22387","article-title":"Anemia is not predictive of sustained virological response in liver transplant recipients with hepatitis C virus who are treated with pegylated interferon and ribavirin","volume":"17","author":"Giusto","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2013.02.004_b0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00508-006-0704-0","article-title":"Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia","volume":"118","author":"Hofer","year":"2006","journal-title":"Wien Klin Wochenschr"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813001220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813001220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T16:21:02Z","timestamp":1539879662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0168827813001220"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.02.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}